ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
5.04
-0.07 (-1.37%)
At close: Nov 20, 2024, 4:00 PM
5.00
-0.04 (-0.79%)
After-hours: Nov 20, 2024, 4:42 PM EST
ReShape Lifesciences Market Cap
ReShape Lifesciences has a market cap or net worth of $2.55 million as of November 21, 2024. Its market cap has increased by 219.21% in one year.
Market Cap
2.55M
Enterprise Value
2.00M
1-Year Change
219.21%
Ranking
Category
Stock Price
$5.04
Market Cap Chart
Since October 6, 2016, ReShape Lifesciences's market cap has decreased from $238.80M to $2.55M, a decrease of -98.93%. That is a compound annual growth rate of -42.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 3.60M | 9.09% |
| Dec 29, 2023 | 3.30M | - |
| Dec 30, 2022 | 3.30M | -88.70% |
| Dec 31, 2021 | 29.20M | 149.57% |
| Dec 31, 2020 | 11.70M | -19.86% |
| Dec 31, 2019 | 14.60M | -69.77% |
| Dec 31, 2018 | 48.30M | -58.00% |
| Dec 29, 2017 | 115.00M | -22.61% |
| Dec 30, 2016 | 148.60M | -37.77% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ENDRA Life Sciences | 2.69M |
| Fresh2 Group | 2.69M |
| Protagenic Therapeutics | 2.66M |
| Bone Biologics | 2.64M |
| Molecular Templates | 2.55M |
| Petros Pharmaceuticals | 2.48M |
| Scinai Immunotherapeutics | 2.46M |
| Nuwellis | 2.43M |